ATEC
HealthcareAlphatec Holdings, Inc. · Medical - Devices · $1B
What is Alphatec Holdings, Inc.?
Alphatec Holdings is a medical technology company focused exclusively on the surgical treatment of spinal disorders. Based in Carlsbad, California, it develops proprietary systems designed to improve surgical precision and patient outcomes across a range of spine procedures.
Alphatec generates revenue by designing, developing, and commercializing surgical technologies for spine surgery. Its product portfolio spans neural monitoring systems, spinal fixation platforms, interbody implants, and biologics — sold primarily to hospitals and surgical centers. The company focuses on enabling surgeons to perform complex spinal procedures with greater safety and anatomical accuracy, differentiating itself through integrated intraoperative intelligence tools alongside its hardware and implant offerings.
Alphatec Holdings was founded in 2006 and is headquartered in Carlsbad, California.
- SafeOp Neural InformatiX System for intraoperative nerve monitoring
- Invictus Spinal Fixation System for thoracolumbar pathologies
- Sigma transforaminal lumbar interbody fusion access system
- Squadron lateral retractor for minimally invasive access
- Biologics including cervical structural allograft spacers
Is ATEC a Good Stock to Buy?
UQS Score rates ATEC as Below Average overall, reflecting meaningful gaps in quality and competitive moat despite notable growth momentum.
The Growth pillar stands out as the clearest bright spot in ATEC's profile, suggesting the company is expanding its commercial footprint at a pace that outpaces many peers in the spine technology space. Valuation is rated Good, meaning the market may not be pricing in excessive optimism relative to where the business currently stands.
Both the Quality and Moat pillars are rated Weak, pointing to concerns around financial durability and the company's ability to defend its market position against larger, better-resourced spine device competitors.
See the full pillar breakdown and underlying financial metrics by signing up for a UQS Pro account. Sign up free →
Past performance does not guarantee future results. UQS Score is based on fundamental data and is not a buy/sell recommendation.
Does ATEC pay dividends?
No — Alphatec Holdings, Inc. does not currently pay a dividend.
ATEC does not currently pay a dividend. For a growth-stage medical technology company, this is typical — available capital is directed toward product development, sales force expansion, and clinical infrastructure rather than shareholder distributions. Investors in ATEC are generally seeking capital appreciation rather than income.
When does ATEC report earnings?
Alphatec Holdings reports earnings on a quarterly cadence, consistent with standard practice for US-listed equities.
ATEC's recent reporting periods have reflected its growth-oriented profile, with revenue expansion remaining a central narrative. Profitability metrics remain a work in progress, which is consistent with the Weak Quality pillar rating in the UQS framework.
For the most current quarterly results and guidance, visit Alphatec Holdings' investor relations page directly.
ATEC Price History
-27.7% over 5Y
Monthly close, adjusted for stock splits and dividend reinvestment.
What if I invested in Alphatec Holdings, Inc.?
Based on Alphatec Holdings, Inc.'s historical closing prices, adjusted for stock splits and dividend reinvestment. Past performance does not guarantee future results. This is for informational purposes only and is not financial advice.
ATEC Long-term Outlook
ATEC's Strong Growth pillar suggests the company's commercial trajectory remains upward, supported by continued adoption of its spine surgery platforms. However, the Weak Quality and Moat ratings introduce meaningful uncertainty — sustained growth without improving financial durability can leave the business exposed during periods of market stress or competitive pressure. The Neutral Risk rating indicates the overall risk profile is neither extreme nor particularly low, and the Good Valuation label suggests the current price may offer some cushion relative to fundamentals.
Growth drivers
- Expanding surgeon adoption of integrated neural monitoring and fixation systems
- Growing addressable market for minimally invasive spine surgery procedures
- Ongoing product line extensions across fixation, access, and biologics categories
Key risks
- Weak moat leaves ATEC vulnerable to competition from larger spine device companies
- Weak Quality pillar signals financial sustainability concerns that could limit operational flexibility
- Execution risk in scaling a complex surgical product portfolio against well-capitalized incumbents
ATEC vs Peers
ATEC operates in a competitive medical device landscape alongside companies that serve adjacent or overlapping segments of the healthcare market.
Inspire focuses on implantable neurostimulation therapy for sleep apnea rather than spine surgery, representing a different but comparably growth-oriented medical device niche.
AdaptHealth operates as a home medical equipment provider, serving patients post-procedure — a distribution-focused model that contrasts with ATEC's surgical technology approach.
UFP Technologies manufactures specialty packaging and components for medical devices, positioning it as a materials and manufacturing partner rather than a direct surgical technology competitor.
Frequently Asked Questions
What does Alphatec Holdings do?
Alphatec Holdings designs and commercializes surgical technologies for treating spinal disorders. Its portfolio includes neural monitoring systems, spinal fixation platforms, interbody implants, and biologics — all aimed at helping surgeons perform spine procedures more safely and effectively.
Does ATEC pay dividends?
No, ATEC does not currently pay a dividend. As a growth-stage medical technology company, it reinvests available capital into product development and commercial expansion rather than returning cash to shareholders through distributions.
When does ATEC report earnings?
Alphatec Holdings reports earnings on a quarterly cadence, as is standard for US-listed companies. For exact dates and the most recent results, check the investor relations section of the Alphatec Holdings website.
Is ATEC a good stock to buy?
UQS Score rates ATEC as Below Average overall. The Growth pillar is Strong and Valuation is Good, but Weak ratings in both Quality and Moat highlight real concerns about financial durability and competitive positioning. The full pillar breakdown is available to UQS Pro members.
Is ATEC overvalued?
The UQS Valuation pillar for ATEC is rated Good, suggesting the stock is not obviously overpriced relative to its current fundamentals. That said, valuation should always be considered alongside quality and risk — both of which are rated Weak for ATEC.
How does ATEC compare to its competitors?
ATEC competes in the spine surgery technology space against a range of medical device companies. Its differentiation lies in combining intraoperative neural monitoring with a broad fixation and implant portfolio. Compared to peers in the UQS universe, its Growth pillar stands out, while Quality and Moat lag.
What is ATEC's market cap bracket?
ATEC is classified as a small-cap company. This places it in a segment of the market that can offer higher growth potential but also carries greater volatility and liquidity risk compared to large- or mega-cap peers in the medical device sector.
Who founded Alphatec Holdings?
Alphatec Holdings was founded in 2006. Detailed founding history and leadership background are publicly available through the company's official investor relations materials and SEC filings.
Is ATEC a long-term quality investment?
From a long-term quality perspective, ATEC's UQS profile presents a mixed picture. The Strong Growth pillar indicates commercial momentum, but Weak Quality and Moat ratings suggest the business has not yet built the financial resilience or competitive durability typically associated with high-quality long-term holdings.
What is the main competitive advantage of Alphatec Holdings?
ATEC's primary differentiation is its integration of intraoperative neural monitoring — through the SafeOp platform — with a comprehensive suite of spinal fixation and implant systems. This combination targets a surgeon's need for both safety intelligence and procedural hardware in a single ecosystem.
What sector does ATEC belong to?
ATEC operates in the Healthcare sector, specifically within medical technology and surgical devices. It focuses exclusively on the spine surgery segment, which is a specialized and competitive niche within the broader medical device industry.
Is ATEC a growth stock or value stock?
Based on its UQS pillar profile, ATEC leans toward the growth category — its Growth pillar is rated Strong. The Valuation pillar is rated Good, meaning it is not priced at an extreme premium, but the primary investment thesis centers on revenue expansion rather than deep value characteristics.
Unlock Full ATEC Analysis
Sign in to unlock the detailed analysis behind the UQS Score.
- ✓View exact UQS Score and all five pillar ratings
- ✓Access underlying financial metrics driving each pillar
- ✓Compare ATEC against sector peers side by side
- ✓Track score changes across quarterly reporting cycles
- ✓Screen for stocks with stronger Quality and Moat profiles
- ✓Get the complete analyst-style breakdown in one place
Pro Analysis
ATEC — Score History
| Date | UQS | Quality | Moat | Growth | Risk | Value | Change |
|---|---|---|---|---|---|---|---|
| May 23, 2026 | 46.8 | 17.9 | 21.0 | 86.5 | 48.5 | 83.4 | 0.0 |
| May 21, 2026 | 46.8 | 17.9 | 21.0 | 86.5 | 48.5 | 83.6 | 0.0 |
| May 20, 2026 | 46.8 | 17.9 | 21.0 | 86.5 | 48.5 | 83.7 | -0.1 |
| May 19, 2026 | 46.9 | 17.9 | 21.0 | 86.5 | 48.5 | 84.3 | -0.4 |
| May 16, 2026 | 47.3 | 17.9 | 21.0 | 86.5 | 48.5 | 86.4 | 0.0 |
| May 15, 2026 | 47.3 | 17.9 | 21.0 | 86.5 | 48.5 | 86.9 | -0.1 |
| May 14, 2026 | 47.4 | 17.9 | 21.0 | 86.5 | 48.5 | 87.0 | +0.2 |
| May 13, 2026 | 47.2 | 17.9 | 21.0 | 86.5 | 48.5 | 86.0 | -0.7 |
| May 12, 2026 | 47.9 | 17.9 | 21.0 | 86.5 | 48.5 | 90.4 | +0.5 |
| May 11, 2026 | 47.4 | 17.9 | 21.0 | 86.5 | 48.5 | 87.2 | +4.1 |
ATEC — Pillar Breakdown
Quality
— 17.9/100 (25%)Alphatec Holdings, Inc. currently shows below-average quality metrics, suggesting challenges with profitability.
How effectively capital is deployed to generate returns.
Profitability relative to shareholders' equity.
Ability to convert revenue into operating profit.
Bottom-line profit as a share of revenue.
Asset productivity — how much gross profit each dollar of assets generates.
Free cash flow relative to market value.
Growth
— 86.5/100 (20%)Alphatec Holdings, Inc. is growing rapidly with strong revenue and earnings expansion.
Revenue trajectory over the last twelve months.
Compound annual revenue growth rate over 3 years.
Year-over-year earnings per share growth.
Analyst consensus for future revenue growth.
Analyst consensus for future earnings growth.
Risk
— 48.5/100 (15%)Alphatec Holdings, Inc. has some risk factors including moderate leverage or solvency concerns.
Debt levels relative to earnings capacity.
Total debt relative to shareholder equity.
Short-term liquidity — ability to pay near-term obligations.
Earnings capacity relative to interest payments.
Valuation
— 83.4/100 (15%)Alphatec Holdings, Inc. appears attractively valued relative to its earnings, cash flows, and sector peers.
Inverse of forward P/E — higher yield means cheaper stock.
P/E relative to earnings growth — lower is more attractive.
Moat
— 21/100 (25%)Alphatec Holdings, Inc. operates in a highly competitive environment with limited sustainable advantages. The Moat pillar evaluates competitive advantages across five dimensions: Switching Costs, Network Effects, Cost Advantage, Intangible Assets, and Scale & Ecosystem. Sign in to customize moat ratings for ATEC.
Score Composition
Financial Data
More Stock Analysis
How is the ATEC UQS Score Calculated?
The UQS (Unified Quality Score) for Alphatec Holdings, Inc. is calculated using a proprietary 6-pillar framework with 29 financial metrics. Each pillar evaluates a different dimension on a 0–100 scale, then combines into a single weighted score. Scoring thresholds are calibrated per sector. Momentum is an optional Pro toggle — without it, you get the 5-pillar / 25-metric core shown below.
Quality (25%) measures profitability and capital efficiency — ROIC, ROE, margins, GP/Assets, and FCF Yield.
Moat (25%) assesses Alphatec Holdings, Inc.'s competitive advantages across switching costs, network effects, cost advantages, intangible assets, and ecosystem scale.
Growth (20%) tracks revenue trajectory and earnings momentum, combining historical results with analyst forward estimates.
Risk (15%) is inversely scored — lower leverage and strong balance sheet health result in higher scores.
Valuation (15%) measures whether Alphatec Holdings, Inc. is fairly priced using earnings yield, price-to-FCF, PEG ratio, and EV/EBITDA relative to sector peers.
Six investor-inspired presets are available, each with different pillar weights: Balanced, Buffett, Munger, Lynch, Cathie Wood, and Graham. The public score shown here uses the Balanced preset. Learn more in our FAQ.